Literature DB >> 22044680

Fighting resistant tuberculosis with old compounds: the carbapenem paradigm.

J L Mainardi1, J E Hugonnet, L Gutmann, M Arthur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22044680     DOI： 10.1111/j.1469-0691.2011.03699.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  12 in total

1.  Negative Impact of Carbapenem Methylation on the Reactivity of β-Lactams for Cysteine Acylation as Revealed by Quantum Calculations and Kinetic Analyses.

Authors:  Nicholus Bhattacharjee; Sébastien Triboulet; Michel Arthur; Catherine M Bougault; Vincent Dubée; Matthieu Fonvielle; Zainab Edoo; Jean-Emmanuel Hugonnet; Mélanie Ethève-Quelquejeu; Jean-Pierre Simorre; Martin J Field
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.

Authors:  Daria Soroka; Inès Li de la Sierra-Gallay; Vincent Dubée; Sébastien Triboulet; Herman van Tilbeurgh; Fabrice Compain; Lluis Ballell; David Barros; Jean-Luc Mainardi; Jean-Emmanuel Hugonnet; Michel Arthur
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

3.  Acyl acceptor recognition by Enterococcus faecium L,D-transpeptidase Ldtfm.

Authors:  Sébastien Triboulet; Catherine M Bougault; Cédric Laguri; Jean-Emmanuel Hugonnet; Michel Arthur; Jean-Pierre Simorre
Journal:  Mol Microbiol       Date:  2015-07-17       Impact factor: 3.501

4.  Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins.

Authors:  Vincent Dubée; Sébastien Triboulet; Jean-Luc Mainardi; Mélanie Ethève-Quelquejeu; Laurent Gutmann; Arul Marie; Lionel Dubost; Jean-Emmanuel Hugonnet; Michel Arthur
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

5.  Kinetic analysis of Enterococcus faecium L,D-transpeptidase inactivation by carbapenems.

Authors:  Vincent Dubée; Michel Arthur; Hélène Fief; Sébastien Triboulet; Jean-Luc Mainardi; Laurent Gutmann; Matthieu Sollogoub; Louis B Rice; Mélanie Ethève-Quelquejeu; Jean-Emmanuel Hugonnet
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

6.  In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.

Authors:  Mathilde Cordillot; Vincent Dubée; Sébastien Triboulet; Lionel Dubost; Arul Marie; Jean-Emmanuel Hugonnet; Michel Arthur; Jean-Luc Mainardi
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

7.  Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactams.

Authors:  Maia K Schoonmaker; William R Bishai; Gyanu Lamichhane
Journal:  J Bacteriol       Date:  2014-01-24       Impact factor: 3.490

Review 8.  Have we realized the full potential of β-lactams for treating drug-resistant TB?

Authors:  Elizabeth Story-Roller; Gyanu Lamichhane
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

9.  Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.

Authors:  Rajappan Revathi; Ramachandran Venkatesha Perumal; Karkala Sreedhara Ranganath Pai; Govindakarnavar Arunkumar; Dharmarajan Sriram; Suvarna Ganesh Kini
Journal:  Drug Des Devel Ther       Date:  2015-07-21       Impact factor: 4.162

10.  Kinetic features of L,D-transpeptidase inactivation critical for β-lactam antibacterial activity.

Authors:  Sébastien Triboulet; Vincent Dubée; Lauriane Lecoq; Catherine Bougault; Jean-Luc Mainardi; Louis B Rice; Mélanie Ethève-Quelquejeu; Laurent Gutmann; Arul Marie; Lionel Dubost; Jean-Emmanuel Hugonnet; Jean-Pierre Simorre; Michel Arthur
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.